Annual Meeting held in Chicago, IL, was host to a State of the Science session on novel diagnostics and therapeutics in renal cell and urothelial carcinomas. Dr. Wulff-Burchfield discussed strategies ...

EBC-129 has been granted FDA fast track designation for the treatment of pancreatic ductal adenocarcinoma, paving the way for ...

Therapeutic target identification and corresponding drug development is a demanding task for the treatment of lung adenocarcinoma, especially the most malignant proximal-proliferative subtype without ...

1 Department of internal medicine, William Beaumont Hospital, Royal Oak, Michigan, USA 2 Department of internal medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA ...

This is the highest reported objective response rate of any systemic treatment in unresectable hepatocellular carcinoma, surpassing atezolizumab–bevacizumab (30%) 11 and STRIDE (20%). 13 However, this ...

The leading Metastatic Merkel Cell Carcinoma Companies such as Incyte Corporation, Merck, Pfizer, Millennium Pharmaceuticals ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Nasopharyngeal Cancer Pipeline ...

1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

“I just got out of surgery about an hour ago. I had my appendix removed. I also had 14 new endometriosis lesions that had to be removed, and they kindly stitched up my hernia, as well,” she adde ...

Methods: A Markov model with three health states was developed to assess the cost-effectiveness of CAD-CHM in HER2-negative advanced G/GEJ adenocarcinoma. Clinical efficacy data were sourced from the ...